A study recently released in Public Health Reports—the official journal of the U.S. Surgeon General—used data from NASADAD’s 2015 inquiry on States’ efforts to address prescription drug misuse and heroin use to describe how States are combatting the opioid epidemic. The article, titled How States Are Tackling the Opioid Crisis, is the first of its kind to quantify and summarize State-level efforts to combat prescription drug and opioid addiction. As federal initiatives by Department of Health and Human Services (HHS) and the Office of National Drug Control Policy (ONDCP) aim to improve substance use disorder prevention and treatment, this article outlines the critical role that States—in particular the State alcohol and drug agencies—have in addressing the opioid crisis. The initiatives undertaken by States that are highlighted in the article include:
- Educating the general public, prescribers, patients and families, and pharmacists about the risks of opioids;
- Increasing funding for medication-assisted treatment;
- Expanding the availability of naloxone;
- Establishing guidelines for safe opioid prescribing;
- Requiring prescriber use of prescription monitoring programs;
- Enacting Good Samaritan laws to protect those helping treat overdoses; and
- Enacting legislation to regulate pain clinics.
Authors offer a review of the literature, noting that State alcohol and drug agencies’ efforts to address opioid misuse and addiction align with intervention models that have been previously evaluated. The article recognizes that State alcohol and drug agencies have demonstrated a robust response to the opioid crisis, and concludes that future efforts should “focus on maintenance and further expansion of the high-quality, evidence-based practices, policies, and programs” that States are already implementing.
Read the full article here.
NASADAD has released a section-by-section summary of the 21st Century Cures Act, which was signed into law by President Obama in December 2016. The Cures Act was originally designed to promote innovations in medical research, but the Act, as signed into law, contains numerous other initiatives, including several provisions related to substance use disorders.
Access the section-by-section summary here.
- Presentation to the National Conference of State Legislatures on opioids (Aug 2016)
- Presentation to the American Congress of Obstetricians and Gynecologists (Mar 2016)
- Presentation to the Criminal Justice Executive Directors Round Table (Jan 2016)
- Presentation to the National Conference of State Legislatures, Health and Human Services Committee (Dec 2015)
- Presentation to the National Conference of State Legislatures, Criminal Justice & Public Safety Committee (Dec 2015)
- Presentation to the National Governors Association, Criminal Justice Policy Advisers on Opioid Abuse (Apr 2015)
- Presentation to the Senate HELP Committee on Opioid Abuse (Jun 2014)
- Presentation to Office of National Drug Control Policy (ONDCP) on Opioids (Jun 2014)
- Presentation at APHA Annual Conference on Prescription Drug Misuse/Abuse (Nov 2013)
- Presentation to National Conference of State Legislatures (NCSL) on Marijuana (May 2013)
- Debt Ceiling Background Powerpoint (Dec 2010)
- NASADAD Presents before Institute Legislative Liaisons at the National Institutes of Health (NIH) (Oct 2010)
- “NASADAD Presentation at the New England Institute of Addiction Studies, Burlington, Vermont, by Robert Morrison, NASADAD Executive Director” (Jun 2010)